[Ip-health] Pfizer R&D Unit relocating to China

Outterson, Kevin mko at bu.edu
Wed Mar 16 09:48:52 PDT 2011

The next time that PhRMA or USTR tries to link IP issues in a trade agreement to R&D jobs, ask them about this article from Fierce Biotech:  http://tinyurl.com/5skytn2

Pfizer's R&D unit isn't moving to "high IP" countries with recent trade agreements with PhRMA-inspired IP chapters (Australia, Korea, Singapore, Jordan, etc.) but to China.  The move has nothing to do with IP rules in China.

Kevin Outterson
Associate Professor
Editor in Chief, Journal of Law, Medicine & Ethics

More information about the Ip-health mailing list